Prostatectomy Procedure
Description, Latest Information and Doctors

Save information for later
Sign Up

Learn About Prostatectomy

Who are the top Prostatectomy Local Doctors?
Elite in Prostatectomy
Elite in Prostatectomy

Cleveland Clinic Main Campus

2050 East 96th Street, 
Cleveland, OH 
Experience:
37+ years
Languages Spoken:
English

Jihad Kaouk is a Urologist practicing medicine in Cleveland, Ohio. He has been practicing medicine for over 37 years. Dr. Kaouk is rated as an Elite provider by MediFind in Prostatectomy. He is also highly rated in 31 other conditions, according to our data. His clinical expertise encompasses Renal Cell Carcinoma (RCC), Prostate Cancer, Horseshoe Kidney, Nephrectomy, and Prostatectomy. Dr. Kaouk is board certified in American Board Of Urology, 2013.

Elite in Prostatectomy
Elite in Prostatectomy
675 N St Clair St Ste 20-150, Galter Pavilion, 
Chicago, IL 
Experience:
25+ years
Languages Spoken:
English
Offers Telehealth

Edward Schaeffer is an Oncologist practicing medicine in Chicago, Illinois. He has been practicing medicine for over 25 years. Dr. Schaeffer is rated as an Elite provider by MediFind in Prostatectomy. He is also highly rated in 5 other conditions, according to our data. His clinical expertise encompasses Prostate Cancer, Familial Prostate Cancer, Bladder Cancer, Prostatectomy, and Ureteroscopy. Dr. Schaeffer is board certified in American Board Of Urology - Urology (Certified).

 
 
 
 
Learn about our expert tiers
Learn More
Elite in Prostatectomy
Elite in Prostatectomy

UT Southwestern - Urology

2001 Inwood Rd, 4th Fl, 
Dallas, TX 
Languages Spoken:
English, German
Offers Telehealth

"A world-renowned urologist and expert on cancerous prostate diseases, Claus Roehrborn, M.D.</strong>, has been practicing at UT Southwestern for more than 20 years and has been Chair of the Department of Urology</a> since 2002. Under his leadership, the Department has consistently been named among the nation's best by U.S. News & World Report.Dr. Roehrborn's practice focuses on the treatment of prostate cancer and benign prostatic hyperplasia (BPH). Over the past several years, he has performed more than 1,200 robotic prostatectomies for prostate cancer and more than 800 laser prostatectomies for BPH, making him one of the country's most experienced surgeons in the use of robotic procedures for urologic conditions. In addition, he is involved in virtually all aspects of BPH research as well as translational and clinical research in prostatitis and prostate cancer.Born and raised in the former West Germany, Dr. Roehrborn earned his medical degree from Justus Liebig University in Giessen and began his residency in surgery and urology at the German Army Hospital there. He was initially drawn to urology during medical school because of the comprehensive nature of the specialty that allows physicians to see patients, do their own medical tests, diagnose their conditions, operate on them if necessary, and then do follow-up care.In 1984 Dr. Roehrborn moved to Dallas and continued his studies at UT Southwestern where he received advanced training in urologic endocrinology. He became a faculty member of UT Southwestern in 1992.In 2018, Dr. Roehrborn was included in D Magazine</em>'s Best Doctors list and was named a Super Doctor by Texas Monthly</em>. In 2010, he was the recipient of the Patricia and William L. Watson Jr., M.D., Award for Excellence in Clinical Medicine, which recognizes a UT Southwestern clinician whose work exemplifies a commitment to outstanding patient care and advancement of innovative medical therapy. The recipient of the award is chosen by a panel of colleagues and peers.". Dr. Roehrborn is rated as an Elite provider by MediFind in Prostatectomy. He is also highly rated in 33 other conditions, according to our data. His clinical expertise encompasses Enlarged Prostate (BPH), Prostate Cancer, Familial Prostate Cancer, Aquablation, and Prostatectomy.

What are the latest Prostatectomy Clinical Trials?
Phase II Study Evaluating the Effects of Single Site Intratumoral Injections of Anti-CD40 Agonist Antibody (2141-V11) Given as Monotherapy Prior to Radical Prostatectomy to Men With Intermediate Risk Disease and in Combination With Androgen Deprivation Therapy for Those With High Risk Localized and Low Volume Metastatic Disease

Summary: The purpose of this study is to see whether combining 2141-V11 with various standard treatments is an effective treatment approach for prostate cancer. 2141-V11 works by activating the immune system to find and kill cancer cells. Researchers will look at whether this treatment approach is able to completely get rid of cancer in participants, and they will check for the presence of minimal residual...

Match to trials
Find the right clinical trials for you in under a minute
Get started
Expanding an Active Surveillance Cohort to Improve Survivorship for Men With Favorable Risk Prostate Cancer

Summary: The overarching goal is to prospectively recruit men considering active surveillance for treatment in the MAGIC (MRI And GPS Informing Choices for prostate cancer treatment) Cohort to provide meaningful data on active surveillance in Blacks and in men served in safety net hospitals. Recent studies highlight significant promise for multi-parametric magnetic resonance imaging of the prostate (MRI) a...